Today: 7 February 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Airbnb Stock Jumps on AI Upgrades and Travel Boom – Is a Bigger Rally Ahead?

Airbnb (ABNB) Stock Today — November 6, 2025: Shares Jump After Hours as Q3 Revenue Beats and Q4 Outlook Tops Estimates

Summary: Airbnb (NASDAQ: ABNB) closed lower in regular trading but spiked in after-hours after reporting Q3 2025 results that topped revenue expectations and offered an above-consensus Q4 sales outlook. Here’s everything investors need to know today, November 6, 2025. Key takeaways ABNB price action on November 6, 2025 Context: The after-hours bounce reflects investors’ relief on revenue momentum and Q4 guidance that edges past the Street, despite a modest EPS miss. Reuters+1 Q3 2025: What stood out Guidance and early Q4 signals Where growth is coming from Airbnb continues to outgrow in expansion markets relative to core geographies: Product &
6 November 2025
Alien Probe or Cosmic Relic? Interstellar Comet 3I/ATLAS Baffles Scientists (updated 27.10.2025)

Comet 3I/ATLAS News Roundup (Nov. 6, 2025): China’s Mars Orbiter Images the Interstellar Visitor, JWST Chemistry Update, and How to See It

Comet 3I/ATLAS news roundup — November 6, 2025 Today’s big development: China’s Tianwen‑1 Mars orbiter captured and released new images of the interstellar comet 3I/ATLAS (also cataloged as C/2025 N1), taken from roughly 30 million km away during the comet’s October 3 pass near Mars. China’s state outlets say the sequence shows clear cometary features and marks one of the closest probe‑based looks at the object to date. The observation doubles as a technology pathfinder for China’s upcoming Tianwen‑2 mission. State Council of China+2Xinhua News+2 What the Tianwen‑1 images add Context: ESA’s TGO produced the closest European look on Oct.
6 November 2025
··
Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

NVO Stock Today (Nov 6, 2025): Novo Nordisk volatile as White House pricing deal reshapes GLP‑1 market—what it means for Wegovy, Ozempic and investors

Published: November 6, 2025 TL;DR: Novo Nordisk’s U.S.‑listed shares (NYSE: NVO) swung after the White House announced a pricing-and-access deal with Novo and Eli Lilly that expands Medicare coverage for anti‑obesity drugs and cuts out‑of‑pocket costs. As of 17:51 UTC (12:51 p.m. ET), NVO traded around $47.30, down ~2.4% on the day (intraday range: $46.91–$49.49; volume ~29.3M). The company confirmed a Medicare Part D pilot beginning in 2026, lower U.S. prices in Medicare/Medicaid and cash channels, and a three‑year tariff exemption—and flagged a low single‑digit drag to 2026 global sales growth. GlobeNewswire What’s moving NVO today White House deal cuts
6 November 2025
··
NYSE Skyrockets to Record Highs as AI Frenzy, Fed Rate Cut Bets Fuel Stock Surge

Why Stocks Are Down Today (Nov. 6, 2025): Tech Sell‑Off, Shutdown Data Void, and Tariff Uncertainty Hit Wall Street

Key takeaways What the market is doing right now Stocks were broadly lower midday Thursday (around 12:30 p.m. ET): the Dow was off by roughly 0.9% (~‑400 to ‑500 points), the S&P 500 down a little over 1%, and the Nasdaq nearly ‑2% as megacaps and chipmakers led declines. A live markets snapshot showed the S&P 500 near 6,710 (‑1.3%), Dow near 46,850 (‑1.0%), and Nasdaq near 23,022 (‑2.0%). AP News+1 The “why” behind today’s sell‑off 1) Tech and AI valuation hangover Wall Street’s leadership group—mega‑cap tech and AI‑exposed names—came under renewed pressure after a brief respite Wednesday. Semiconductor shares
6 November 2025
····
Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Novo Nordisk Stock Today (Nov 6, 2025): NVO steadies as White House GLP‑1 pricing deal lands; $10B Metsera bidding war heats up

Date: Thursday, November 6, 2025Ticker: NVO (NYSE) At a glance: price action and catalysts Novo Nordisk stock traded around $47.36 as of 17:52 UTC, after opening at $47.75 and moving between $46.91–$49.49 on heavy volume. The tape is being driven by two big headlines: (1) a White House pricing agreement that expands access to GLP‑1 drugs across Medicare/Medicaid and a new direct‑to‑consumer channel, and (2) a $10 billion bidding battle with Pfizer for obesity‑drug startup Metsera. What changed today 1) White House pricing deal lowers GLP‑1 costs and expands coverage The administration announced a deal with Novo Nordisk and Eli
6 November 2025
··
Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

Dow Jones Today (Nov. 6, 2025): Stocks Slide as Tech Sells Off; Layoffs Surge and FAA Orders Flight Cuts Amid Shutdown

NEW YORK — Thursday, November 6, 2025. U.S. stocks fell sharply in late‑morning trading, with the Dow Jones Industrial Average down more than 400 points (≈0.9%) as renewed selling in mega‑cap tech weighed on the broader market. The Nasdaq led losses at nearly 2%, while the S&P 500 was lower by a little over 1%. Concerns over stretched AI‑linked valuations, a spike in announced layoffs, and mounting disruption from the federal shutdown kept risk appetite in check. MarketWatch+2The Wall Street Journal+2 What’s moving markets Dow Jones today: by the numbers (intraday) Biggest drags on the Dow Salesforce (CRM) and Amazon
6 November 2025
···
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly (LLY) Pops as White House Strikes Obesity-Drug Pricing Deal; New 20% Weight‑Loss Data Fuels Momentum — Today, November 6, 2025

Eli Lilly stock today: drivers, numbers, and what to watch for next. Key takeaways (Nov 6, 2025) Eli Lilly stock today: quote & range As of this afternoon, LLY traded near $935.89, up about 1.1%, with today’s range $916.37–$949.90 and a 52‑week range $624.00–$955.43 (values delayed up to 15 minutes). Reuters 1) The White House’s obesity‑drug deal: lower prices, broader access President Donald Trump announced deals with Eli Lilly and Novo Nordisk to reduce U.S. costs and expand coverage for in‑demand weight‑loss medicines. The plan includes Medicare coverage for obesity treatment, expected to carry $50 monthly copays for eligible beneficiaries,
6 November 2025
··
Palantir (PLTR) Stock Soars on AI Hype – Is It a Bubble or the Next Tech Giant?

Palantir (PLTR) slips ~5.7% as new marketing & smart‑city deals land — What’s moving the stock today (Nov. 6, 2025)

Updated Nov. 6, 2025 — 16:47 UTC Live price (intraday)As of 16:47 UTC, Palantir shares trade at $177.24, roughly ‑5.7% on the day, after opening at $188.00 and ranging between $176.97–$190.94 so far. Key takeaways What happened today (Nov. 6) 1) Two partnership headlines hit before and during the session 2) Price action in context Today’s decline extends the post‑earnings valuation shake‑out seen since Tuesday despite significant beats and a strong outlook. Reuters reported Palantir’s Q4 guide above estimates and reiterated concerns from some market participants about the implied slowdown from ~63% Q3 growth to ~61% in Q4 and still‑lofty
6 November 2025
····
Oracle (ORCL) Stock Rockets 70% on AI Frenzy – Jim Cramer Warns “It’s the Only One I’m Worried About”

Oracle (ORCL) Stock Today — November 6, 2025: Price Slides as AI-Spend Scrutiny Builds; Fresh AI Database Coverage, Gartner ‘Leader’ Nod, and New OCI Partnerships in Focus

Live ORCL snapshot (Nov 6, 2025): As of 16:38 UTC, Oracle shares trade at $241.00, down about 3.7% on the day, after ranging between $239.45–$251.41 on intraday volume of ~8.0M shares. What’s moving Oracle stock today 1) Investors wrestle with the OpenAI overhang.A fresh Business Insider write‑up this morning highlights how skepticism over OpenAI’s ability to fund its sprawling, multi‑year AI compute contracts has weighed on ORCL after September’s historic spike. The piece underscores that Oracle’s 36% single‑day surge on Sept. 10—driven by mammoth AI‑cloud wins—has since faded as markets discount execution risk on those deals. Business Insider 2) Oracle’s
6 November 2025
····
Meta’s $1.5B AI Hiring Spree: Will Zuckerberg’s Talent Grab Send META Stock Soaring & Shake Up Apple’s XR Plans?

Meta (META) Stock Today: Shares Slip ~2% as Reuters Probes Scam Ads and MPA Challenges Instagram’s ‘PG‑13’ Claim — Nov 6, 2025

Updated: Nov 6, 2025, 11:37 a.m. ET Quick takeaways Meta stock at a glance (Nov 6, 2025) By late morning, META changed hands near $620.70, down $15.25 from yesterday’s close of $635.95 (‑2.4%). Intraday volume was just over 10 million shares at the time of publication, with the session low at $619.26. Meta’s market capitalization hovered near $1.85 trillion and its P/E was ~31.5. Year‑over‑year, the stock remains well above its 52‑week low ($479.80) but below the high ($796.25) set earlier this year. Reuters What’s moving Meta today 1) Reuters investigation spotlights revenue from scam ads A fresh Reuters Special
6 November 2025
···
Battle of the EV Charging Standards: Tesla’s NACS vs. CCS2 vs. CHAdeMO – Who Will Rule the Roads in 2025?

Tesla Stock Today (Nov 6, 2025): TSLA Slides as Shareholders Vote on Elon Musk’s $1T Pay Package; Cybertruck Order Shift Adds Fresh Jitters

Date: Thursday, November 6, 2025 At a glance (intraday):Price: $438.86 (-5.0%) as of 16:37 UTC (11:37 a.m. ET)Day range: $438.06 – $467.17Open: $461.97; Volume: ~44.8M Key takeaways What’s moving Tesla today 1) The vote that could redefine Tesla’s governance (and its stock) Shareholders are being asked to approve an unprecedented Musk pay plan, described in major outlets as $878B to as much as $1T in potential stock awards tied to multi‑year milestones (vehicle volumes, robotaxi scale, and market‑value thresholds into the multi‑trillion range). The company has framed this as critical to retaining Musk and aligning incentives with long‑term AI/robotics ambitions.
6 November 2025
····
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Google Stock Today (Nov 6, 2025): Epic Settlement, DOJ Clears $32B Wiz Deal, AI Expansion — GOOGL/GOOG Price, News & What to Watch

Ticker: Alphabet Inc. (NASDAQ: GOOGL, GOOG) • Date: Thursday, Nov 6, 2025 (6.11.2025) At a glance: Alphabet shares were little changed midday as investors weighed a proposed settlement with Epic Games that would reshape Google’s Android app-store economics, fresh progress on the $32 billion Wiz acquisition, and new AI‑driven infrastructure and sustainability moves. As of publication, GOOGL traded around $283 with an intraday range near $281–$290 and a market cap of roughly $2.94T. Key takeaways Today’s market driver #1: Epic settlement proposal could reset Play Store economics Alphabet and Epic Games told the court they’ve reached a “comprehensive” settlement proposal that,
6 November 2025
···
1 … 285 286 287 288 289 … 586

Stock Market Today

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

7 February 2026
Carvana shares rose 5.21% Friday to $403.67, rebounding after recent volatility sparked by a short-seller report from Gotham City Research. The company denied allegations of overstated earnings and undisclosed ties to DriveTime. Carvana will report Q4 and full-year 2025 results after markets close on Feb. 18. The January U.S. CPI report is scheduled for Feb. 13.
Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

7 February 2026
Confluent shares closed at $30.57 Friday, 43 cents below IBM’s $31-per-share cash offer, ahead of key events next week. The company will report earnings Feb. 11 without a call or outlook, and shareholders vote on the merger Feb. 12. Confluent disclosed 17 demand letters and two lawsuits over proxy disclosures but denies wrongdoing. The IBM deal values Confluent at $11 billion.
Go toTop